XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Income Statement [Abstract]        
Net sales $ 607,071 $ 658,880 $ 1,828,850 $ 1,900,646
Cost of sales 380,200 402,059 1,122,190 1,122,258
Gross profit 226,871 256,821 706,660 778,388
Selling, general, and administrative expenses 87,204 90,219 270,057 258,820
Research and development expenses 25,484 25,752 77,270 68,796
Amortization of intangibles 16,022 15,567 49,773 39,883
Restructuring, impairment, and other charges 4,516 3,413 13,221 4,265
Total operating expenses 133,226 134,951 410,321 371,764
Operating income 93,645 121,870 296,339 406,624
Interest expense 10,101 8,399 29,803 17,069
Foreign exchange loss 11,776 18,191 8,697 40,051
Other (income) expense, net (3,527) (698) (11,810) 9,789
Income before income taxes 75,295 95,978 269,649 339,715
Income taxes 17,507 20,510 53,045 59,713
Net income $ 57,788 $ 75,468 $ 216,604 $ 280,002
Earnings per share:        
Basic (in dollars per share) $ 2.32 $ 3.05 $ 8.72 $ 11.32
Diluted (in dollars per share) $ 2.30 $ 3.02 $ 8.63 $ 11.21
Weighted-average shares and equivalent shares outstanding:        
Basic (in shares) 24,893 24,755 24,838 24,726
Diluted (in shares) 25,143 24,988 25,100 24,986